8-K//Current report
Ultragenyx Pharmaceutical Inc. 8-K
Accession 0000950170-21-000388
$RARECIK 0001515673operating
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 9:00 AM ET
Size
172.1 KB
Accession
0000950170-21-000388
Documents
- 8-Krare-20210624.htmPrimary
8-K
- EX-101.SCHrare-20210624.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- EX-101.LABrare-20210624_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.PRErare-20210624_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- XMLrare-20210624_htm.xml
IDEA: XBRL DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0000950170-21-000388-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001515673
Filing Metadata
- Form type
- 8-K
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 9:00 AM ET
- Size
- 172.1 KB